A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
Clinical trial NCT04633252 · RECRUITING
Trial details
- NCT number
- NCT04633252
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-23
- Primary completion
- 2026-12-31
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.